BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2319038)

  • 1. Electron microscopic observations of dyskeratosis, apoptosis, colloid bodies and fibrillar degeneration after skin irritation with dithranol.
    Kanerva L
    J Cutan Pathol; 1990 Feb; 17(1):37-44. PubMed ID: 2319038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
    Kanerva L
    Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular and branched Birbeck granules and cytomembrane blebbing in Langerhans' cells after dithranol irritation.
    Kanerva L
    Acta Derm Venereol; 1989; 69(5):407-9. PubMed ID: 2572106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line.
    George SE; Anderson RJ; Haswell M; Groundwater PW
    J Pharm Pharmacol; 2013 Apr; 65(4):552-60. PubMed ID: 23488784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis in human HaCaT keratinocytes.
    Henseleit U; Rosenbach T; Kolde G
    Arch Dermatol Res; 1996 Oct; 288(11):676-83. PubMed ID: 8931870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
    Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of normal human skin to single and repeated applications of dithranol cream: an immunohistochemical assessment.
    Swinkels OQ; Prins M; Birker LW; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):262-9. PubMed ID: 12218288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis. Its nature and implications for dermatopathology.
    Weedon D; Searle J; Kerr JF
    Am J Dermatopathol; 1979; 1(2):133-44. PubMed ID: 44963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposure.
    Kosten IJ; Spiekstra SW; de Gruijl TD; Gibbs S
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):35-42. PubMed ID: 26028481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of perforin-mediated apoptosis in lichen planus lesions.
    Kastelan M; Prpić Massari L; Gruber F; Zamolo G; Zauhar G; Coklo M; Rukavina D
    Arch Dermatol Res; 2004 Oct; 296(5):226-30. PubMed ID: 15452725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the cellular and subcellular reactions in epidermis at irritant and allergic dermatitis.
    Lindberg M
    Acta Derm Venereol Suppl (Stockh); 1982; 105():1-45. PubMed ID: 6962642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of Langerhans cells in dermatology].
    Lipozencić J; Ljubojević S
    Arh Hig Rada Toksikol; 2004 Jun; 55(2-3):167-74. PubMed ID: 15285465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
    Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
    Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dithranol-induced cytotoxicity in primary cultures of rat epidermal keratinocytes. I. The role of reactive oxygen species.
    Hsieh GC; Acosta D
    Toxicol Appl Pharmacol; 1991 Jan; 107(1):16-26. PubMed ID: 1846245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes and Langerhans cells in patch tests. An immunohistochemical and electron microscopic study.
    Kanerva L; Ranki A; Lauharanta J
    Contact Dermatitis; 1984 Sep; 11(3):150-5. PubMed ID: 6388994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.
    Kaplan G; Walsh G; Guido LS; Meyn P; Burkhardt RA; Abalos RM; Barker J; Frindt PA; Fajardo TT; Celona R
    J Exp Med; 1992 Jun; 175(6):1717-28. PubMed ID: 1588289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H; Mustakallio KK
    Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.